Abbott’s Humira receives FDA approval for expanded use

Abbott’s blockbuster rheumatoid arthritis drug, Humira, has been approved by the US FDA for a new use – to treat patients with moderate to severe ulcerative colitis. Abbott Laboratories Inc.’s drug, Humira, has been approved for the treatment of moderate to…